Results 21 to 30 of about 1,205,764 (269)

Effect of Ayurvedic interventions as add-on therapy in Huntington's disease: A case report

Journal of Ayurveda Case Reports, 2022
Huntington's disease (HD) is a rare autosomal dominant neurodegenerative disorder. It is caused due to trinucleotide cytosine-adenine-guanine (CAG) repeat expansion on chromosome 4.
B Malavika, HP Savitha
doaj   +1 more source

Acute Opioid-Induced Myoclonic Reaction after Use of Fentanyl as an Anesthetic Drug for an Emergency Cesarean Section

Case Reports in Neurology, 2018
Myoclonus is an abnormal involuntary movement that has been previously reported with administration of high doses of opioids for prolonged periods of time.
Dana Khaled Almedallah, Dana Yousef Alshamlan, Erum Mubbashir Shariff   +2 more
doaj   +1 more source

Chorea-ballism as a dominant clinical manifestation in heteroplasmic mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome with A3251G mutation in mitochondrial genome: a case report

Journal of Medical Case Reports, 2019
Background Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes, the most common maternally inherited mitochondrial disease, can present with a wide range of neurological manifestations including both central and peripheral nervous ...
Durjoy Lahiri, Vishal Madhukar Sawale, Subhadeep Banerjee, Souvik Dubey, Biman Kanti Roy, Shyamal Kumar Das   +5 more
doaj   +1 more source

Disminución de las discinesias en un modelo de Parkinson en ratas Wistar, mediada por el fitofármaco Mucuna pruriens

Neurology Perspectives, 2021
Resumen: La enfermedad de Parkinson (EP) es una enfermedad neurodegenerativa cuyo tratamiento sintomático más eficaz es la L-dopa, sin embargo, puede inducir discinesias (DIL).
J.C. Guzman, C.A. Otalora, P. Caro, E.L. Mayorga, J.P. Alcazar, L.F. Turner   +5 more
doaj   +1 more source

Abnormal Involuntary Movements in Neuroleptic-Naive Children and Adolescents [PDF]

The Canadian Journal of Psychiatry, 1999
Objective: To determine the prevalence of and identify risk factors for abnormal involuntary movements in a well-characterized community sample of neuroleptic-naive children and adolescents. Method: The Abnormal Involuntary Movement ...
M, Magulac, J, Landsverk, S, Golshan, D V, Jeste   +3 more
openaire   +2 more sources

Riluzole Administration to Rats with Levodopa-Induced Dyskinesia Leads to Loss of DNA Methylation in Neuronal Genes

Cells, 2021
Dyskinesias are characterized by abnormal repetitive involuntary movements due to dysfunctional neuronal activity. Although levodopa-induced dyskinesia, characterized by tic-like abnormal involuntary movements, has no clinical treatment for Parkinson’s ...
Luca Pagliaroli, Abel Fothi, Ester Nespoli, Istvan Liko, Borbala Veto, Piroska Devay, Flora Szeri, Bastian Hengerer, Csaba Barta, Tamas Aranyi   +9 more
doaj   +1 more source

Real-World Patterns of Botulinum Toxin Treatment in Hyperkinetic Movement Disorders: A 9-Year Nationwide Analysis in France. [PDF]

Mov Disord Clin Pract
Abstract Background Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT‐A). Real‐world evidence on treatment patterns remains limited. Objective This nationwide, population‐based study aimed to evaluate trends in BoNT‐A use in France between 2015 and 2023 ...
Simonetta-Moreau M, Karam P, Forestier A, Degos B.   +3 more
europepmc   +2 more sources

Involuntary movements in adults with intellectual disability [PDF]

, 2014
Involuntary movements in adults with intellectual disability are not sufficiently researched manifestation. There are numerous causes of the emergence of involuntary movement in this population.
Đurić-Zdravković, Aleksandra, Japundža-Milisavljević, Mirjana   +1 more
core   +1 more source

Diaphragmatic flutter in a patient with a pacemaker

Clinical Management Issues, 2015
Diaphragmatic flutter is a rarely reported disorder characterized by an abnormal diaphragmatic activity, which may be associated with respiratory symptoms (respiratory myoclonus).
Carlo Bussolino, Laura Massarelli, Valter Saracco   +2 more
doaj   +1 more source

Basal ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia

Frontiers in Neuroanatomy, 2010
Involuntary movements, or dyskinesia, represent a debilitating complication of levodopa therapy for Parkinson’s disease. Dyskinesia are, ultimately, experienced by the vast majority of the patients.
Pedro eBarroso Chinea, Erwan eBezard
doaj   +1 more source